Natera PE Ratio 2014-2025 | NTRA
Current and historical p/e ratio for Natera (NTRA) from 2014 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Natera PE ratio as of January 14, 2026 is 0.00.
| Natera PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-14 | 239.19 | 0.00 | |
| 2025-09-30 | 160.97 | $-2.29 | 0.00 |
| 2025-06-30 | 168.94 | $-1.91 | 0.00 |
| 2025-03-31 | 141.41 | $-1.47 | 0.00 |
| 2024-12-31 | 158.30 | $-1.53 | 0.00 |
| 2024-09-30 | 126.95 | $-1.76 | 0.00 |
| 2024-06-30 | 108.29 | $-2.45 | 0.00 |
| 2024-03-31 | 91.46 | $-3.12 | 0.00 |
| 2023-12-31 | 62.64 | $-3.79 | 0.00 |
| 2023-09-30 | 44.25 | $-4.52 | 0.00 |
| 2023-06-30 | 48.66 | $-4.82 | 0.00 |
| 2023-03-31 | 55.52 | $-5.35 | 0.00 |
| 2022-12-31 | 40.17 | $-5.57 | 0.00 |
| 2022-09-30 | 43.82 | $-5.68 | 0.00 |
| 2022-06-30 | 35.44 | $-6.06 | 0.00 |
| 2022-03-31 | 40.68 | $-5.88 | 0.00 |
| 2021-12-31 | 93.39 | $-5.17 | 0.00 |
| 2021-09-30 | 111.44 | $-4.58 | 0.00 |
| 2021-06-30 | 113.53 | $-3.67 | 0.00 |
| 2021-03-31 | 101.54 | $-3.10 | 0.00 |
| 2020-12-31 | 99.52 | $-2.81 | 0.00 |
| 2020-09-30 | 72.24 | $-2.38 | 0.00 |
| 2020-06-30 | 49.86 | $-1.99 | 0.00 |
| 2020-03-31 | 29.86 | $-1.72 | 0.00 |
| 2019-12-31 | 33.69 | $-1.81 | 0.00 |
| 2019-09-30 | 32.80 | $-1.86 | 0.00 |
| 2019-06-30 | 27.58 | $-2.02 | 0.00 |
| 2019-03-31 | 20.62 | $-2.16 | 0.00 |
| 2018-12-31 | 13.96 | $-2.23 | 0.00 |
| 2018-09-30 | 23.94 | $-2.59 | 0.00 |
| 2018-06-30 | 18.82 | $-2.61 | 0.00 |
| 2018-03-31 | 9.27 | $-2.51 | 0.00 |
| 2017-12-31 | 8.99 | $-2.60 | 0.00 |
| 2017-09-30 | 12.89 | $-2.45 | 0.00 |
| 2017-06-30 | 10.86 | $-2.44 | 0.00 |
| 2017-03-31 | 8.87 | $-2.38 | 0.00 |
| 2016-12-31 | 11.71 | $-1.85 | 0.00 |
| 2016-09-30 | 11.11 | $-1.60 | 0.00 |
| 2016-06-30 | 12.07 | $-1.49 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $32.905B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.388B | 30.55 |
| HCA Healthcare (HCA) | United States | $109.378B | 18.11 |
| CVS Health (CVS) | United States | $102.418B | 11.78 |
| Elevance Health (ELV) | United States | $82.379B | 12.08 |
| Cencora (COR) | United States | $67.098B | 21.63 |
| DiDi Global (DIDIY) | China | $23.862B | 22.04 |
| Labcorp Holdings (LH) | United States | $21.055B | 16.05 |
| Medpace Holdings (MEDP) | United States | $17.138B | 42.55 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.432B | 0.00 |
| BioMerieux (BMXMF) | France | $15.505B | 0.00 |
| Viatris (VTRS) | United States | $15.399B | 5.74 |
| ICON (ICLR) | Ireland | $14.802B | 14.69 |
| Solventum (SOLV) | United States | $13.881B | 13.47 |
| Revvity (RVTY) | United States | $12.487B | 22.99 |
| CochLear (CHEOY) | Australia | $11.568B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.778B | 20.76 |
| Avantor (AVTR) | United States | $8.591B | 13.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.606B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.449B | 0.00 |
| HealthEquity (HQY) | United States | $7.201B | 26.93 |
| BrightSpring Health Services (BTSG) | United States | $6.965B | 41.53 |
| PACS (PACS) | United States | $6.598B | 40.12 |
| Bausch + Lomb (BLCO) | Canada | $6.181B | 40.58 |
| Sotera Health (SHC) | United States | $5.392B | 26.00 |
| Alignment Healthcare (ALHC) | United States | $4.186B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.175B | 55.76 |
| Concentras Parent (CON) | United States | $2.599B | 16.22 |
| Organon (OGN) | United States | $2.192B | 2.31 |
| Progyny (PGNY) | United States | $2.176B | 42.78 |
| Surgery Partners (SGRY) | United States | $2.080B | 26.80 |
| Pediatrix Medical (MD) | United States | $1.904B | 11.37 |
| Establishment Labs Holdings (ESTA) | United States | $1.893B | 0.00 |
| Ardent Health (ARDT) | United States | $1.266B | 4.13 |
| Teladoc Health (TDOC) | United States | $1.241B | 0.00 |
| Nutex Health (NUTX) | United States | $1.221B | 9.33 |
| CareDx (CDNA) | United States | $1.038B | 16.97 |
| GoodRx Holdings (GDRX) | United States | $0.971B | 15.89 |
| Omada Health (OMDA) | United States | $0.934B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.773B | 0.00 |
| Embecta (EMBC) | United States | $0.750B | 4.26 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.708B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.601B | 0.00 |
| Enhabit (EHAB) | United States | $0.554B | 24.89 |
| CryoPort (CYRX) | United States | $0.538B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.466B | 0.00 |
| SBC Medicals (SBC) | United States | $0.457B | 8.42 |
| Agilon Health (AGL) | United States | $0.394B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.349B | 5.62 |
| Oncology Institute (TOI) | United States | $0.347B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.320B | 67.24 |
| Shoulder Innovations (SI) | United States | $0.280B | 0.00 |
| So-Young (SY) | China | $0.270B | 0.00 |
| KindlyMD (NAKA) | United States | $0.204B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.085B | 0.00 |
| Biodesix (BDSX) | United States | $0.079B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.28 |
| Intelligent Bio Solutions (INBS) | United States | $0.020B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |